**Policy Summary:**
This order, dated January 13, 2016, issued by the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, withdraws Gazette Notification S.O. No. 2947(E) dated October 29, 2015, with immediate effect. The withdrawn notification pertained to the retail price fixation of MoxifloxacinPrednisolone Acetate Ophthalmic Solution (1ml), manufactured by M/s Akums Drugs & Pharmaceuticals Ltd. and marketed by M/s Entod Pharmaceuticals Ltd. This action is taken in exercise of powers conferred by paragraphs 5, 11, and 15 of the Drugs Prices Control Order, 2013, read with S.O. No. 1394(E) dated May 30, 2013. The order is referenced as PN157262016/F. No. 826/2016/D.P.NPPA/Div.II and is signed by Anand Prakash, Dy. Director.
Key Entities Referenced
National Pharmaceutical Pricing Authority: A government regulatory agency in India that controls the prices of pharmaceutical drugs.
Drugs Prices Control Order, 2013: An order issued by the Government of India to regulate the prices of essential drugs.
Ministry of Chemicals and Fertilizers: A ministry in the Government of India.
New Delhi: The capital of India, where the order was issued.
MoxifloxacinPrednisolone Acetate Opthalmic Solution: A pharmaceutical product whose retail price fixation is the subject of the notification.
Akums Drugs Pharmaceuticals Ltd.: A pharmaceutical manufacturer of MoxifloxacinPrednisolone Acetate Opthalmic Solution.
Entod Pharmaceuticals Ltd: A pharmaceutical company that markets MoxifloxacinPrednisolone Acetate Opthalmic Solution.
Mayapuri, New Delhi: Location of Government of India Press